Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 88,932	$ 36,746
Prepaid expenses	743	1,192
Other current assets	218	175
Total current assets	89,893	38,113
Other assets	6	153
Total assets	89,899	38,266
Current liabilities:
Accounts payable and accrued expenses	6,557	5,027
Current portion of operating lease liabilities	0	169
Total current liabilities	6,641	5,196
Contract liabilities, net of current portion	18,669	18,669
Total liabilities	25,462	23,965
Commitments and contingencies
Stockholders’ equity:
Additional paid-in capital	391,090	311,885
Accumulated deficit	(326,692)	(299,718)
Total stockholders’ equity attributable to vTv Therapeutics Inc.	64,437	12,199
Noncontrolling interest	0	2,102
Total stockholders’ equity	64,437	14,301
Total liabilities, redeemable noncontrolling interest and stockholders’ equity	89,899	38,266
Related Party
Current liabilities:
Warrant liability, related party	84	0
Warrant liability	0	57
Nonrelated Party
Current liabilities:
Warrant liability	152	43
Class A Common Stock
Stockholders’ equity:
Common stock value	39	26
Class B Common Stock
Stockholders’ equity:
Common stock value	$ 0	$ 6

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.

Name:	us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.